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Aims and method The SCIMITAR+ trial was commissioned to evaluate the
eﬀectiveness of a bespoke smoking cessation intervention for people with severe
mental ill health compared with usual services. It is diﬃcult to deﬁne what
constitutes usual care in smoking cessation services. We aimed to deﬁne what this
was during the trial. Twenty-two National Health Service healthcare providers
participated in a bespoke survey asking about usual care in their area.
Results All sites oﬀered smoking cessation support; however, service provider and
service type varied substantially. In some cases services were not streamlined,
meaning that people received smoking cessation counselling from one organisation
and smoking cessation medication from another.
Clinical implications To better implement the National Institute for Health and
Care Excellence guideline PH48, clearer referral pathways need to be implemented
and communicated to patients, staﬀ and carers. People with severe mental ill health
need to be able to access services that combine nicotine replacement therapy and
behavioural support in a streamlined manner.
Declaration of interest None.
Keywords Severe mental ill health; smoking cessation; nicotine replacement
therapy; schizophrenia; bipolar aﬀective disorders.
Smoking cessation and severe mental ill health
Smoking is a key health issue for the UK population and a
World Health Organization priority owing to its strong
links to poor physical health, worsened mental health and
conditions such as cancer and heart disease.1 Smoking is
more prevalent amongst people with severe mental ill health
(SMI) and it is estimated that 57–68% of people in the UK
with SMI smoke tobacco.2 Reducing tobacco harm in people
with SMI is therefore of high importance and more focus is
required to facilitate successful quit attempts.
UK primary care guidance on smoking cessation for
patients with SMI suggests that they should be oﬀered a
combination of nicotine replacement therapy (NRT) and
behavioural support, in the same way as to those in the gen-
eral population.3 National Institute for Health and Care
Excellence (NICE) guidance PH48 advises that all mental
health trusts should be smoke-free by 2018,4 and provides
recommendations on eﬀective ways to help people stop
smoking or to abstain from smoking while using or working
in secondary care settings. Public Health England’s subse-
quent guidance for mental health services on implementing
smoke-free policies5 and the Tobacco Control Plan in 20176
further cemented the importance of providing smoking ces-
sation advice for people with SMI. Current literature pri-
marily focuses on smoking cessation care provision for
in-patient rather than community settings. Individuals
with mental health conditions are currently referred to com-
munity cessation services that are available to the general
public, but would likely beneﬁt from programmes tailored
to their needs.1 The Action on Smoking and Health report
recommended speciﬁc action to embed smoking cessation
care in specialist mental health services.
The SCIMITAR+ trial
The Smoking Cessation Intervention for severe Mental Ill
Health Trial (SCIMITAR+) (registered with the
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International Standard Randomised Controlled Trial
Number database, under identiﬁer ISRCTN72955454)7 is
the largest trial, to our knowledge, to evaluate the eﬀective-
ness of a bespoke smoking cessation intervention speciﬁcally
for people with SMI, comparing regular smoking cessation
provision (deﬁned as what was available in the local area)
with adapted and tailored support.7 During the trial it
became apparent that usual care varied across geographical
locations and in some instances even changed. To further
understand what constituted usual care in the sites taking
part in the SCIMITAR+ trial, we asked the sites to complete
a questionnaire describing local smoking cessation services.
This paper therefore describes the existing usual care oﬀered
to people with SMI who sought smoking cessation support
throughout the trial, as identiﬁed from 22 participating
study sites. The aim is to better understand how smoking
cessation interventions are delivered to those with an SMI
diagnosis by adding to the limited information currently
available.
Method
Tool
The SCIMITAR+ trial compared a mental health bespoke
smoking cessation service with usual care. The survey was
developed for the purposes of the SCIMITAR+ trial and pro-
vides an overview on usual care services by describing where
services were provided, by whom, and how they were deliv-
ered. The survey (Appendix) comprised of eight questions,
covering information on the local smoking cessation care
usually provided to people with SMI.
Sample
All 22 centres that had recruited to the SCIMITAR+ trial
were approached. Centres consisted of various primary
and/or secondary care services in urban, suburban and
rural locations across England that had signiﬁcant target
population sizes: Sheﬃeld Health and Social Care
Partnership National Health Service (NHS) Trust, Leeds
and York Partnership NHS Trust, Bradford District Care
NHS Foundation Trust, Sussex Partnership
NHS Foundation Trust, Southern Health NHS Foundation
Trust, Somerset Partnership NHS Foundation Trust,
2gether NHS Foundation Trust, Berkshire Healthcare NHS
Foundation Trust, Rotherham Doncaster and South
Humber NHS Foundation Trust, Oxford Health NHS
Foundation Trust, Northumberland Tyne and Wear
NHS Foundation Trust, Cambridge and Peterborough NHS
Foundation Trust, Camden and Islington NHS Foundation
Trust, Greater Manchester Mental Health NHS
Foundation Trust, Kent and Medway NHS and Social Care
Foundation Trust, Lancashire Care NHS Foundation Trust,
Lincolnshire Partnership NHS Foundation Trust, South
Essex Partnership University NHS Foundation Trust,
Solent NHS Trust, South West Yorkshire NHS Foundation
Trust, Tees Esk and Wear Valleys NHS Foundation Trust
and Vauxhall Primary Healthcare Centre.
Respondents
The research department at each SCIMITAR+ centre was
initially approached in February 2017 and asked to complete
the survey. Contact was made by email in the ﬁrst instance,
followed by a telephone call to the centre if a response was
not provided within two weeks. All 22 centres completed
the survey.
Research departments from each centre investigated
local cessation services that acted as usual care for the
SCIMITAR+ trial and provided results at an organisational
level. This meant that research ethics committee and
Health Research Authority approvals were not required
and consent was implied. Some centres completed multiple
surveys because they covered geographical areas with more
than one smoking cessation commissioning; for example,
Kent and Medway NHS and Social Care Partnership Trust
returned one survey for Kent and one for Medway. This
resulted in 28 survey responses, which are henceforth
referred to as individual sites.
Analysis
Descriptive statistics were produced to identify the availabil-
ity of diﬀerent types of services.
Results
All sites (n = 28) reported data on which organisations pro-
vide smoking cessation support in their region (Table 1).
General practitioners (GPs) (n = 17) and the local council
(n = 16) were the most common usual care service providers,
followed by third-sector organisations (n = 15) and secondary
care trusts (n = 9). However, typically these providers
worked collaboratively with others to deliver smoking cessa-
tion support. It was only in three localities that the local
Table 1 Smoking cessation service provider frequency
Service provider
Frequency
(%)
Local council only 3 (10.7)
GP surgery 2 (7.1)
Secondary care trust 4 (14.3)
Third-sector organisation 4 (14.3)
Local council and GP surgery 1 (3.6)
Local council, GP surgery and secondary care trust 2 (7.1)
Local council, GP surgery and third sector 5 (17.9)
Local council, GP surgery, secondary care trust and
third sector
2 (7.1)
Local council, GP surgery, secondary care trust and
other NHS servicea
1 (3.6)
Local council, GP surgery, third sector and other
NHS service
2 (7.1)
GP surgery, third sector and other NHS service 2 (7.1)
GP, general practitioner; NHS, National Health Service.
a. Other NHS service refers to services provided by an NHS body other than a
GP surgery or mental health trust.
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council alone provided smoking cessation support and in
two localities that GP surgeries alone provided the smoking
cessation support. Third-sector organisations (voluntary and
community organisations such as charities) and secondary
care trusts acted as sole providers in four sites.
Data on the types of behavioural support available was
provided in 27 sites (Table 2). One-to-one, face-to-face sup-
port was oﬀered in all 27 responding sites. Of these,
one-to-one, face-to-face support was oﬀered in eight sites,
one-to-one telephone support was also oﬀered in 16 sites
and group face-to-face support was oﬀered in 15 sites.
Online support in combination with another support type
was oﬀered in eight sites, and three or more options for
behavioural support was oﬀered in 15 sites.
Responses on the profession of those who delivered the
support was provided in 23 sites (Table 3). Multiple profes-
sions were involved in 12 sites and a single profession in
seven sites. Trained nurses were the most frequent support
providers (n = 12); a service delivered by nurses only and a
collaboration with other professionals was available in
three sites. Healthy living advisors were the second most fre-
quent professional, reported to be available in nine sites,
with seven of these instances being in collaboration with
other professionals. Usual care was also delivered within
sites by GP staﬀ (n = 6), usually in collaboration with other
professionals (n = 5), and by mental health staﬀ (n = 6), also
usually in conjunction with other professions (n = 5).
Behavioural support was oﬀered as part of a smoking
cessation service within 25 sites and no response to this
item was provided within the remaining sites (n = 3)
(Table 4). National Centre for Smoking Cessation and
Training (NCSCT) level 2 training was provided to practi-
tioners in 22 sites, with 11 of those sites containing solely
NCSCT level 2 practitioners, and services within ten sites
were delivered by a combination of level 1 and 2
practitioners.
NRT provision data was supplied within 27 sites
(Table 5). NRT was provided by the smoking cessation ser-
vice directly in 12 sites, an NRT prescription from a GP
was required in ﬁve sites and NRT was provided by both
the GP and the smoking cessation service in eight sites.
Finally, it was indicated that usual care changed during
the course of the SCIMITAR+ trial within nine sites
(6 October 2015 to 16 December 2017). Within three sites,
positive changes to service availability were reported
through increased training (n = 2), the secondary care trust
becoming smoke-free (n = 1) and increased signposting (n =
1). Negative changes to service availability were reported
within three sites. Cessation services were decommissioned
within two sites, and in one of these instances, smoking ces-
sation funding was reallocated to drug and alcohol services
who would provide smoking cessation support. Within the
third site, the oﬀer of group support was ceased and further
changes would occur once two local commissioners had
merged. Additionally, a change in service provider during
Table 2 Frequency of type of support oﬀered
Support
Frequency
(%)
Face-to-face one to one 8 (28.6)
Face-to-face one to one and group 3 (10.7)
Face-to-face one to one, group and telephone one
to one
7 (25)
Face-to-face one to one, group, telephone one to
one and online
4 (14.3)
Face-to-face one to one and telephone one to one 1 (3.6)
Face-to-face one to one, telephone one to one and
online
3 (10.7)
Face-to-face one to one, group, telephone one to
one, online and other
1 (3.6)
No data 1 (3.6)
Table 4 Frequency of training level of practitioner who
provided the behavioural support
Training level Frequency (%)
NCSCT level 1 2 (7.1)
NCSCT level 2 11(39.3)
NCSCT level 1 and level 2 8 (28.6)
NCSCT level 2 and other 1 (3.6)
NCSCT level 1, level 2 and other 2 (7.1)
Other 1 (3.6)
No data 3 (10.7)
NCSCT, National Centre for Smoking Cessation and Training.
Table 3 Frequency of type of professional who delivers the
smoking cessation support
Professional
Frequency
(%)
Healthy living advisors 2 (7.1)
Trained nurse 3 (10.7)
Other 4 (14.3)
Mental health professional 1 (3.6)
Healthy living advisors and trained nurse 2 (7.1)
Healthy living advisors and mental health
professional
1 (3.6)
Trained nurse and GP 3 (10.7)
Trained nurse and other 1 (3.6)
Trained nurse and mental health professional 1 (3.6)
Healthy living advisors, GP and mental health
professional
1 (3.6)
Healthy living advisors, nurse and mental health
professional
1 (3.6)
Healthy living advisors, nurse, GP andmental health
professional
1 (3.6)
Healthy living advisors and other 1 (3.6)
GP 1 (3.6)
No data 5 (17.9)
GP, general practitioner.
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the trial was reported in two sites, with one site moving from
GP surgeries to local pharmacies, and many pharmacies
ceasing to provide services in the other site.
Discussion
NICE guidance advises that mental health services should
become completely smoke-free, with all people who use
mental health services being given full access to smoking
cessation interventions.4 There is also a need for services
to take into account the additional challenges that people
with SMI may face when attempting to quit smoking; it is
important to consider that conventional NHS smoking ces-
sation programmes and services may not be suﬃcient for
those with SMI.8 However, where specialist smoking cessa-
tion services are available for people with SMI, these are
generally not suﬃciently evolved or embedded within the
NHS.9
Principal ﬁndings
All geographical locations provided some form of smoking
cessation service, but the service provider, type of service,
support provider profession, smoking cessation practitioner
qualiﬁcations and NRT provider varied substantially across
the country and even within geographical regions. At the
time of the survey in most of the sites, the smoking cessation
service was provided by multiple providers.
One-to-one, face-to-face support was available in all
responding regions, which was in line with NICE guidelines.4
Most sites (67.9%) also oﬀered additional forms of support,
such as group or telephone support, to oﬀer modes of deliv-
ery tailored to patient preferences. There were also individ-
ual cases where the service providers executed their own
strategies for smoking cessation. For instance, one large sec-
ondary care trust began to provide behavioural support and
NRT to pre-empt the impact of enforced smoking cessation
on mental health units. In this trust, all secondary care out-
patients were invited to complete a care plan stating what
type of NRT, if any, they would favour should they be admit-
ted to an in-patient unit. This demonstrates a proactive
approach to support patients through the smoke-free transi-
tion by taking on some service provision responsibilities.
A wide variety of professionals delivered the smoking
cessation support in existing services, both between and
within areas. However, our results show that it was uncom-
mon for a mental health professional to deliver support, lim-
iting the possibility of people with SMI receiving a service
tailored to their mental health needs.
Practitioner training was somewhat standardised across
regions, with staﬀ in almost all sites having NCSCT qualiﬁ-
cations. However, there were diﬀerences in the level of train-
ing that practitioners received. Some practitioners had only
completed level one training, whereas others had attended a
2-day face-to-face training course. Although the NCSCT
Smoking Cessation and Mental Health online module was
available, it is not mandatory for level 1 or 2 training.
Some practitioner training was provided by third-party orga-
nisations, the quality of which could not be veriﬁed.
The provision of NRT also varied across all sites, in part
because of a national trend of transferring NRT provision
from GPs to pharmacies or local councils, which began
before data collection. Thus, in some areas GPs provided
the whole cessation service (behavioural support plus
NRT), whereas in others there was no GP involvement. In
some sites, a prescription for NRT was required from the
patient’s GP despite pharmacies or local councils providing
behavioural support, and in others, the GP provided the
behavioural support but the prescription for NRT needed
to be obtained from the pharmacy or local council.
The diversity across the various aspects of smoking
treatment resulted in multiple service providers contribut-
ing to a single patient’s smoking cessation care. In addition,
in some centres, the provision varied depending on locality
within the service area. This potential complexity of service
provision is also reﬂected by the reported changes to a num-
ber of services during the SCIMITAR+ trial. This may be
confusing for self-referring patients to understand where
to access services and for staﬀ to reliably inform patients
on how to access cessation services, behavioural support
and NRT. This may present a barrier to service access and
a more standardised approach could be considered.
Clinical implications
The lack of uniformed pathway for smoking cessation and
various local initiatives stresses the importance of local
authorities to eﬃciently and eﬀectively disseminate the ser-
vice structure available in their region. Publicly available
localised information for relevant staﬀ to be able to signpost
patients to the correct local service and for patients to self-
refer to the correct local provider is therefore essential in
the eﬀort to reduce the smoking prevalence among people
with SMI. In our SCIMITAR+ trial, for instance, participants
in the bespoke smoking cessation intervention group fed
back to the researchers that they would not have accessed
smoking services without the support of a Mental Health
Smoking Cessation Practitioner, who guided them through
the service. This is reﬂected by the recent Action on
Smoking and Health report1 showing that diverse and frag-
mented services present a challenge to ensuring continuity
of care across diﬀerent parts of the healthcare system for
people with a mental health condition who access cessation
services. Substantial eﬀorts are therefore required to
improve referral pathways to services to make it easier to
people with SMI to access relevant support. Signposting
Table 5 NRT provider frequency
NRT provider
Frequency
(%)
Smoking cessation service 12 (42.9)
GP prescription request 5 (17.9)
Smoking cessation service and GP prescription
request
8 (28.6)
Other 2 (7.1)
No data 1 (3.6)
NRT, nicotine replacement therapy; GP, general practitioner.
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to relevant services could be improved by increasing use of
the NHS Smokefree Local Stop Smoking Services website
that details smoking cessation services by location (www.
nhs.uk/smokefree/help-and-advice/local-support-services-
helplines).9,10
The absence of consistent provision of NRT might not
in itself be a barrier to service access. However, if a patient
has to visit multiple locations to receive both behavioural
support and NRT, it might become an extra burden and dis-
courage them from utilising the full services available, which
could reduce the eﬀectiveness of the service. Furthermore,
in the case of separate provision of behavioural support
and NRT, the lack of communication between the two provi-
ders might become a barrier to realise the full eﬀectiveness
of the services.
Study strengths and limitations
The present survey was a useful tool to describe usual care
and summarise key service components. It successfully cap-
tures diﬀerences between and within the surveyed regions
and has helped to point out the potential challenges to
smoking cessation service provision for those with SMI.
The survey was particularly eﬀective at highlighting and
quantifying the complexity of smoking cessation services
in participating sites in England. The study does not evalu-
ate the eﬀectiveness of usual care services. This paper pro-
vides a description of services and gives an indication of
service accessibility throughout the UK; however, the survey
was not designed to evaluate accessibility nor measure the
numbers of referrals made, service uptake or service success.
These factors, which would provide clearer evidence for or
against some forms of provision, warrant further
exploration.
It is not clear whether multiple service providers oper-
ating in one area improves access by making services more
available or whether this makes it more challenging to iden-
tify the correct referral pathway for both individuals and
clinicians. For sites that reported multiple service or NRT
providers, it was not clariﬁed whether single or multiple
options were available to patients; for example, pharmacies
may issue NRT in one area and local councils may issue it
in another.
Sites were not clearly instructed under what circum-
stances they should complete multiple surveys (for example,
for separate areas within the Trust) and this lack of clarity
may have led to unreliable data. Additionally, the present
survey was completed by research staﬀ and not by those
embedded in clinical teams, which may reduce the reliability
and validity of the data. Although some research staﬀ
reported that they consulted those within clinical teams
for information when they could not ﬁnd it themselves.
All participating sites recruited patients to the
SCIMITAR+ study and hence were interested in smoking
research. This could increase sample bias as these sites
have demonstrated value in improving smoking cessation
services and therefore may have more developed services
than non-participating areas. Use of a wider sampling
method and sampling clinical teams and patients would col-
lect more in-depth data, increase generalisability and
improve evaluation of NICE compliance on a national scale.
Future research
Further research could involve a random sample of patient-
facing NHS staﬀ being asked how they refer patients who
seek smoking cessation support, to ascertain knowledge of
service availability and referral pathways. In addition,
patients who smoke could be surveyed to collect information
on whether they have been referred to cessation services,
whether they are aware of the services available to them
and how they would access those services. This would pro-
vide additional information on how NICE guidelines are
being implemented and how easy it is for NHS staﬀ to imple-
ment the guidance.
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Appendix. Details of usual care form
Site name:________________________________________________
At the current time, who provides Stop Smoking Services in
your area?
Local council □
GP surgery □
Secondary care trust □
Other NHS please state □
Not-for-proﬁt company □
Charity □
Other third-sector organisation, please state______________
How is this support delivered? (Select all which apply)
One-to-one face to face □
One-to-one over the phone □
In a group □
Online support □
Other, please state __________________________
Does this service oﬀer a choice of how the support is
delivered?
Yes □ No □
Does this service provide behavioural support?
Yes □ No □
Who provides the behavioural support?
Trained nurse □
Healthy living advisor □
GP □
Mental health professional □
Other, please state ________________________________________
If the service provides behavioural support what level is the
person providing the support trained to?
NCSCT level 1 □
NCSCT level 2 □
Other training, please state ________________________________
How does a person accessing the service receive NRT?
NRT provided by the service □
Service requests the GP to prescribe □
NRT not available □
Other, please state_________________________________________
Has usual care changed over the course of SCIMITAR+?
Yes □ No □
If yes, please state brieﬂy how it has changed including
details of how usual care was originally delivered at the
start of the study:
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
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